Healthcare Sector Analytics

Market size, company revenue, drug approvals, clinical trials, regulation, hospitals, doctors, drug spending, labs and devices

Brand drugFirst approved 1985

Nitro-Dur(Nitroglycerin)

Medicare prescription drug cost, prescriptions and prescribers, 2024

$2.7M

Medicare cost, 2024

Medicare drug plans spent $2.7 million on Nitro-Dur (nitroglycerin) in 2024, for 1,298 prescriptions and refills filled by 419 patients. Spending fell 21% from 2023 to 2024. At about $2,114 per prescription it is a high-cost drug. California accounts for the most spending ($533,348, 19% of the total).

Medicare cost, 2024

$2.7M

-20.7% from 2023

Prescriptions

1,298

$2,113.89 per claim

Patients

419

443 prescribers

Total spending, 2024

$2.7M

$6,548.51 per patient

Questions and answers

How much does Medicare spend on Nitro-Dur?

Medicare prescription drug plans paid $2.7M for Nitro-Dur in 2024, for 1,298 prescriptions and refills to 419 patients (down 20.7% from 2023). The average cost per claim was $2,113.89.

Which state spends the most on Nitro-Dur?

California had the highest Medicare cost for Nitro-Dur in 2024: $533K for 175 claims, followed by New York ($241K).

Who prescribes Nitro-Dur the most?

James R Orens, internal medicine in Fontana, CA, had the highest Medicare cost for Nitro-Dur in 2024: 19 claims costing $56K.

Spending over the years

Medicare spending by year

All plans and makers

Prescriber data: cost by year

Medicare spending on Nitro-Dur was $2.7M in 2024, after a high of $4.0M in 2021.

By state

Where the prescribers practice, 2024

Medicare cost by state

States with the highest cost

Top prescribers of Nitro-Dur, 2024

By Medicare drug cost

PrescriberTypeClaimsPatientsCost
James R Orens Fontana, CAInternal Medicine19Under 11$56K
Boris Khorets Brooklyn, NYInternal Medicine17Under 11$27K
James W Gainer Elkins, WVFamily Practice12Under 11$21K
Jason T Bradley Lubbock, TXCardiology13Under 11$20K
Dennis M Carroll Lincoln, ILFamily Practice12Under 11$20K
Todd S Fergus Green Bay, WICardiology13Under 11$20K
James R Palen Cape Girardeau, MOFamily Practice12Under 11$20K
Theodore G Rose Garden Grove, CAInternal Medicine12Under 11$19K
Diana M Kim Los Angeles, CACardiology12Under 11$19K
Kelly D Ford Boston, MAInternal Medicine12Under 11$19K
Sara S Foster Ithaca, NYNurse Practitioner12Under 11$19K
Chenna Reddy Nalabolu Baton Rouge, LAInternal Medicine11Under 11$18K
Thomas Pitoscia Millburn, NJInternal Medicine11Under 11$17K
Bobbi J Debbout Green Bay, WINurse Practitioner11Under 11$17K
Jeffrey W Bomber Findlay, OHFamily Practice11Under 11$15K
Khalid A Noori North Babylon, NYInternal Medicine15Under 11$12K
Michael F Powell Thomson, GAInternal Medicine13Under 11$7,330

Prescriber data by year

YearPrescribersClaimsPatientsCost
20225501,736524$3.4M
20234691,547450$3.5M
20244431,298419$2.7M

Makers, 2024

Spending by manufacturer as listed in the spending data

ManufacturerClaimsSpending
Ingenus Pharmac1,298$2.7M

Medicaid spending by quarter

Amount reimbursed by state Medicaid programs, all states

Amount reimbursed

Codes

National drug codes (packages)
6
RxNorm concept IDs
486146, 486148, 486152, 861657, 899521
Application numbers
NDA020145

More drugs: Medicare drug spending and the Prescriptions view.

Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.

LinkedInLinkedInXXYouTubeYouTube